来自诱导瘤抑制细胞的抗癌,用于抑制骨髓瘤细胞
Chang-Peng Cui1,2, Qing-Ji Huo1,2, Xue Xiong1,2
1Department of Pharmacology, School of Pharmacy, Harbin Medical University Harbin 150081, Heilongjiang, China.
American journal of cancer research
|October 11, 2023
概括
研究人员确定了一种新型,P05,来自瘤抑制细胞,显示强大的骨髓瘤 (OS) 抑制. 这种可以有效地向癌细胞而不损害健康的骨细胞,为OS治疗提供了一个有前途的新途径.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 细胞生物学 细胞生物学
背景情况:
- 骨髓瘤 (OS) 是一种主要影响年轻人的骨癌.
- 先进的OS经常转移到肺部,这给治疗带来了重大挑战.
- 目前的结合手术和化疗的治疗方法对晚期或转移性OS的疗效较低.
研究的目的:
- 为了识别和评估新的抗骨髓瘤 (OS) 候选者.
- 评估这些对OS细胞系的疗效.
- 研究由诱导性瘤抑制细胞 (iTSCs) 衍生的的潜力,用于OS治疗.
主要方法:
- 对iTSC的秘密组分析以获得候选物.
- 在OS细胞系上对的有效性进行了体外评估.
- 测试测量代谢活动,增殖,运动和入侵.
- 对非OS骨细胞的效应的评估.
- 对蛋白调节的分析 (EGFR,Snail, Src).
主要成果:
- P05是一种阿尔多酶A (ALDOA) 的片段,表现出最强烈的OS抑制活性.
- 当P05与西斯普拉丁和多克索鲁比辛结合时,显示了添加效应.
- 在OS细胞中,P05降低了包括EGFR,牛和Src在内的关键上蛋白的调节.
- P05对介质干细胞或骨质母细胞没有抑制作用.
结论:
- 来自iTSC的秘密体是发现抗癌的可行来源.
- P05显示出作为骨肉瘤的向治疗剂的显著潜力.
- P05需要进一步研究其在治疗骨髓瘤的临床应用.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy
539
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
539
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


